InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Trimarchi Thomas. Insider active across 1 company, notably BridgeBio Pharma, Inc.. Aggregated, 14 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €1.8m. Activity tracked since 6 August 2024. The latest transaction was disclosed on 16 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Trimarchi Thomas is a declarant linked to BridgeBio Pharma, Inc., where he is President and CFO. He has 13 filings in total, and across the 13 sampled filings, reported sell volume is EUR 1799769 with no reported buys, over the period from 2024-08-08 to 2026-03-20. The most common transaction nature is Retenue fiscale.